Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the amplatzer occlusion device: No evidence for thrombus deposition with antiplatelet agents

Journal of the American Society of Echocardiography

Volumn 15, Issue 10 I, 2002, Pages 1094-1098

  Brandt, Roland R ^a   Neumann, Thomas ^b   Neuzner, Jörg ^b   Rau, Matthias ^b   Faude, Ingrid ^b   Hamm, Christian W ^b  

^a KERCKHOFF HEART CENTER   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; CLOPIDOGREL; PHENPROCOUMON;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEVICE; DRUG SAFETY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HEART SURGERY; HUMAN; MALE; SHUNTING; SURGICAL TECHNIQUE; THROMBOEMBOLISM; THROMBOGENICITY; THROMBOSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; VALSALVA MANEUVER; ADOLESCENT; AGED; ARTIFICIAL EMBOLISM; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART CATHETERIZATION; HEART DISEASE; HEART SEPTUM DEFECT; HEART VENTRICLE SEPTUM; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; CARDIAC SURGICAL PROCEDURES; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; EMBOLIZATION, THERAPEUTIC; FEMALE; HEART CATHETERIZATION; HEART DISEASES; HEART SEPTAL DEFECTS, ATRIAL; HEART SEPTUM; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; THROMBOSIS;

EID: 0038554424     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1067/mje.2002.121666     Document Type: Article

References (25)

1. Konstantinides S, Geibel A, Olschewski M, Gornandt L, Roskamm H, Spillner G, et al. A comparison of surgical and medical therapy for atrial septal defect in adults. N Engl J Med 1995;333:469-73.
2. Murphy JG, Gersh BJ, McGoon MD, Mair DD, Porter CJ, Ilstrup DM, et al. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med 1990;323:1645-50.
3. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984; 59:17-20.
4. de Belder MA, Tourikis L, Leech G, Camm AJ. Risk of patent foramen ovale for thromboembolic events in all age groups. Am J Cardiol 1992;69:1316-20.
5. Hausmann D, Mugge A, Daniel WG. Identification of patent foramen ovale permitting paradoxic embolism. J Am Coll Cardiol 1995;26:1030-8.
6. Dearani JA, Ugurlu BS, Danielson GK, Daly RC, McGregor CG, Mullany CJ, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999;100:II171-5.
7. Homma S, Di Tullio MR, Sacco RL, Sciacca RR, Smith C, Mohr JP. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 1997;28:2376-81.
8. Galal MO, Wobst A, Halees Z, Hatle L, Schmaltz AA, Khougeer F, et al. Peri-operative complications following surgical closure of atrial septal defect type II in 232 patients - a baseline study. Eur Heart J 1994;15:1381-4.
9. Sharafuddin MJ, Gu X, Titus JL, Urness M, Cervera-Ceballos JJ, Amplatz K. Transvenous closure of secundum atrial septal defects: preliminary results with a new self-expanding nitinol prosthesis in a swine model. Circulation 1997;95:2162-8.
10. Windecker S, Wahl A, Chatterjee T, Garachemani A, Eberli FR, Seiler C, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation 2000;101:893-8.
11. Fischer G, Kramer HH, Stieh J, Harding P, Jung O. Transcatheter closure of secundum atrial septal defects with the new self-centering Amplatzer septal occluder. Eur Heart J 1999; 20:541-9.
12. Thanopoulos BD, Laskari CV, Tsaousis GS, Zarayelyan A, Vekiou A, Papadopoulos GS. Closure of atrial septal defects with the Amplatzer occlusion device: preliminary results. J Am Coll Cardiol 1998;31:1110-6.
13. Waight DJ, Koenig PR, Cao QL, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: clinical experience and technical considerations. Curr Interv Cardiol Rep 2000;2:70-7.
14. Walsh KP, Wilmshurst PT, Morrison WL. Transcatheter closure of patent foramen ovale using the Amplatzer septal occluder to prevent recurrence of neurological decompression illness in divers. Heart 1999;81:257-61.
15. Hanley PC, Tajik AJ, Hynes JK, Edwards WD, Reeder GS, Hagler DJ, et al. Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. J Am Coll Cardiol 1985;6:1370-82.
16. Kaulitz R, Paul T, Hausdorf G. Extending the limits of transcatheter closure of atrial septal defects with the double umbrella device (CardioSEAL). Heart 1998;80:54-9.
17. Rickers C, Hamm C, Stern H, Hofmann T, Franzen O, Schrader R, et al. Percutaneous closure of secundum atrial septal defect with a new self centering device ("angel wings") Heart 1998;80:517-21.
18. Rome JJ, Keane JF, Perry SB, Spevak PJ, Lock JE. Doubleumbrella closure of atrial defects. Initial clinical applications. Circulation 1990;82:751-8.
19. Sideris EB, Sideris SE, Thanopoulos BD, Ehly RL, Fowlkes JP. Transvenous atrial septal defect occlusion by the buttoned device. Am J Cardiol 1990;66:1524-6.
20. Sievert H, Babic UU, Hausdorf G, Schneider M, Hopp HW, Pfeiffer D, et al. Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial). Am J Cardiol 1998;82:1405-13.
21. Chan KC, Godman MJ, Walsh K, Wilson N, Redington A, Gibbs JL. Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): multicentre UK experience. Heart 1999;82:300-6.
22. Ewert P, Berger F, Daehnert I, van Wees J, Gittermann M, Abdul-Khaliq H, et al. Transcatheter closure of atrial septal defects without fluoroscopy: feasibility of a new method. Circulation 2000;101:847-9.
23. Daniel WG. Transcatheter closure of patent foramen ovale. Therapeutic overkill or elegant management for selected patients at risk. Circulation 1992;86:2013-5.
24. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group. Neurology 1996;46:1301-5.
25. Gorter JW. Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Neurology 1999;53:1319-27.